Income Statement Interpace Biosciences, Inc.

Stocks

IDXG

US46062X3035

Healthcare Facilities & Services

Market Closed - OTC Markets 22:33:28 13/08/2026 +03			5-day change	1st Jan Change
1.670 ^USD	0.00%		+1.83%	+35.75%

08-10	Interpace Biosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-12	Interpace Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

aeee407962b04.bBlWvfXfYB_KmaaHIcRxP460zdUcBNmEC3Hdha861NY.ClcX2K-eE3OjysCzV7QjT-v-iJNQNLDHeAC18sFY7Lwpbzz5gLMxfvP2xQ

Published financial data: INTERPACE BIOSCIENCES, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	41.31M	31.84M	40.21M	46.93M	38.73M
Total Revenues	41.31M	31.84M	40.21M	46.93M	38.73M
Cost of Goods Sold, Total	23.37M	13.61M	16.31M	17M	14.6M
Gross Profit	17.94M	18.23M	23.9M	29.92M	24.13M
Selling General & Admin Expenses, Total	23.74M	20.1M	19.6M	21.14M	18.7M
R&D Expenses	1.88M	703K	636K	676K	642K
Amortization of Goodwill and Intangible Assets - (IS)	4.06M	1.27M	861K	-	-
Other Operating Expenses, Total	29.68M	22.07M	21.09M	21.82M	19.35M
Operating Income	-11.74M	-3.84M	2.81M	8.11M	4.78M
Interest Expense, Total	-920K	-1.01M	-1.01M	-659K	-168K
Net Interest Expenses	-920K	-1.01M	-1.01M	-659K	-168K
Other Non Operating Income (Expenses)	-509K	-1.21M	-667K	-499K	-142K
EBT, Excl. Unusual Items	-13.17M	-6.06M	1.14M	6.95M	4.47M
Restructuring Charges	-	-	-	-	-700K
Merger & Related Restructuring Charges	-2.58M	-	-	-	-
Asset Writedown	-	-	-	-	-
Other Unusual Items	338K	223K	-7K	-	-
EBT, Incl. Unusual Items	-15.41M	-5.84M	1.13M	6.95M	3.77M
Income Tax Expense	-667K	29K	17K	4K	-21.21M
Earnings From Continuing Operations	-14.75M	-5.86M	1.11M	6.95M	24.98M
Earnings Of Discontinued Operations	-197K	-16.09M	-310K	-244K	-409K
Net Income to Company	-14.94M	-21.96M	802K	6.7M	24.58M
Net Income - (IS)	-14.94M	-21.96M	802K	6.7M	24.58M
Preferred Dividend and Other Adjustments	-	-	-	464K	-
Net Income to Common Incl Extra Items	-14.94M	-21.96M	802K	6.24M	24.58M
Net Income to Common Excl. Extra Items	-14.75M	-5.86M	1.11M	6.48M	24.98M
Per Share Items
Net EPS - Basic	-3.61	-5.18	0.19	1.42	5.55
Basic EPS - Continuing Operations	-3.57	-1.38	0.26	1.48	5.65
Basic Weighted Average Shares Outstanding	4.14M	4.24M	4.32M	4.39M	4.42M
Net EPS - Diluted	-3.62	-5.18	0.18	0.39	0.89
Diluted EPS - Continuing Operations	-3.57	-1.38	0.25	0.41	0.9
Diluted Weighted Average Shares Outstanding	4.14M	4.24M	4.36M	15.73M	27.7M
Normalized Basic EPS	-1.99	-0.89	0.16	0.99	0.63
Normalized Diluted EPS	-1.99	-0.89	0.16	0.28	0.1
Supplemental Items
EBITDA	-6.66M	-1.28M	3.84M	8.41M	5.21M
EBITA	-7.67M	-2.57M	3.67M	8.11M	4.78M
EBIT	-11.74M	-3.84M	2.81M	8.11M	4.78M
EBITDAR	-5.46M	-380K	4.64M	9.11M	5.81M
Effective Tax Rate - (Ratio)	4.33	-0.5	1.51	0.06	-562
Current Domestic Taxes	-705K	29K	17K	4K	44K
Total Current Taxes	-705K	29K	17K	4K	44K
Deferred Domestic Taxes	38K	-	-	-	-21.25M
Total Deferred Taxes	38K	-	-	-	-21.25M
Normalized Net Income	-8.23M	-3.79M	710K	4.34M	2.8M
Interest on Long-Term Debt	-	-	-	-	168K
Supplemental Operating Expense Items
Selling and Marketing Expenses	10.07M	9.12M	10.23M	11.66M	9.42M
General and Administrative Expenses	13.67M	10.97M	9.36M	9.49M	9.28M
Research And Development Expense From Footnotes	1.88M	703K	636K	676K	642K
Net Rental Expense, Total	1.2M	900K	800K	700K	600K
Imputed Operating Lease Interest Expense	957K	541K	473K	433K	229K
Imputed Operating Lease Depreciation	243K	359K	327K	267K	371K
Stock-Based Comp., Other (Total)	1.37M	1.24M	630K	291K	35K
Total Stock-Based Compensation	1.37M	1.24M	630K	291K	35K

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	3.06M	4.83M	3.5M	1.46M	2.5M
Total Cash And Short Term Investments	3.06M	4.83M	3.5M	1.46M	2.5M
Accounts Receivable, Total	6.16M	5.03M	4.98M	8.54M	5.65M
Other Receivables	-	-	-	-	-
Total Receivables	6.16M	5.03M	4.98M	8.54M	5.65M
Inventory	1.79M	1.22M	1.23M	1.21M	1.11M
Prepaid Expenses	800K	390K	590K	535K	632K
Restricted Cash	250K	-	-	-	-
Other Current Assets, Total	108K	680K	24K	22K	-
Total Current Assets	12.17M	12.15M	10.32M	11.77M	9.9M
Gross Property Plant And Equipment	14.62M	5.3M	5.2M	5.82M	5.91M
Accumulated Depreciation	-4.24M	-2.38M	-2.54M	-2.84M	-3.27M
Net Property Plant And Equipment	10.38M	2.92M	2.65M	2.97M	2.64M
Goodwill	8.43M	-	-	-	-
Other Intangibles, Total	7.29M	861K	0	-	-
Deferred Tax Assets Long-Term	-	-	-	-	21.25M
Other Long-Term Assets, Total	160K	45K	45K	45K	44K
Total Assets	38.43M	15.98M	13.02M	14.79M	33.84M
Liabilities
Accounts Payable, Total	2.69M	1.05M	1.54M	1.66M	983K
Accrued Expenses, Total	9.69M	7.9M	9.04M	3.33M	2.7M
Current Portion of Long-Term Debt	-	2.5M	5.1M	4.29M	-
Current Portion of Leases	1.12M	578K	377K	383K	431K
Current Income Taxes Payable	245K	262K	261K	262K	296K
Unearned Revenue Current, Total	40K	-	-	-	-
Other Current Liabilities	1.89M	1.99M	1.15M	695K	695K
Total Current Liabilities	15.68M	14.28M	17.47M	10.62M	5.1M
Long-Term Debt	9.44M	11.16M	4.24M	-	-
Long-Term Leases	3.15M	1.85M	1.47M	1.18M	752K
Unearned Revenue Non Current	13K	-	-	-	-
Other Non Current Liabilities	6.02M	5.22M	4.97M	5.21M	5.62M
Total Liabilities	34.31M	32.52M	28.16M	17.01M	11.48M
Preferred Stock Convertible	46.54M	46.54M	46.54M	-	-
Total Preferred Equity	46.54M	46.54M	46.54M	-	-
Common Stock, Total	403K	405K	405K	406K	407K
Additional Paid In Capital	186M	188M	188M	235M	235M
Retained Earnings	-227M	-249M	-248M	-235M	-211M
Treasury Stock	-1.87M	-1.98M	-2.01M	-2.05M	-2.07M
Total Common Equity	-42.42M	-63.07M	-61.67M	-2.22M	22.36M
Total Equity	4.12M	-16.54M	-15.14M	-2.22M	22.36M
Total Liabilities And Equity	38.43M	15.98M	13.02M	14.79M	33.84M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	4.23M	4.31M	4.38M	4.42M	27.7M
ECS Total Common Shares Outstanding	4.2M	4.3M	4.35M	4.41M	4.54M
Book Value / Share	-10.11	-14.68	-14.17	-0.5	4.93
Tangible Book Value	-58.14M	-63.93M	-61.67M	-2.22M	22.36M
Tangible Book Value Per Share	-13.86	-14.88	-14.17	-0.5	4.93
Total Debt	13.72M	16.09M	11.19M	5.86M	1.18M
Net Debt	10.65M	11.26M	7.69M	4.4M	-1.32M
Debt Equivalent Oper. Leases	9.6M	7.2M	6.4M	5.6M	4.8M
Account Code - Inventory Valuation	3	3	3	3	3
Inventories - Others	1.79M	1.22M	1.23M	1.21M	1.11M
Machinery, Total	8.51M	2.54M	2.81M	3.47M	3.96M
Full Time Employees	147	94	108	111	102
Part Time Employees	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	72K	-	-	-	-

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-14.94M	-21.96M	802K	6.7M	24.58M
Depreciation & Amortization - CF	1.01M	1.29M	740K	748K	821K
Amortization of Goodwill and Intangible Assets - (CF)	4.06M	1.27M	861K	-	-
Depreciation & Amortization, Total	5.07M	2.56M	1.6M	748K	821K
Amortization of Deferred Charges, Total - (CF)	422K	60K	42K	-	58K
(Gain) Loss From Sale Of Asset	-2K	-71K	-	-	-
Asset Writedown & Restructuring Costs	-	12.4M	-	-	198K
Stock-Based Compensation (CF)	1.37M	1.3M	630K	291K	35K
Provision and Write-off of Bad Debts	-140K	-	-	-	-
Other Operating Activities, Total	633K	1.06M	797K	581K	-21.14M
Change In Accounts Receivable	2.15M	-133K	49K	-3.47M	2.9M
Change In Accounts Payable	-1.82M	-735K	489K	120K	-807K
Change in Unearned Revenues	-	-	-	-	-
Change in Other Net Operating Assets	-1.46M	-2.18M	-621K	-330K	-800K
Cash from Operations	-8.72M	-7.69M	3.79M	4.65M	5.83M
Capital Expenditure	-354K	-322K	-470K	-876K	-356K
Sale of Property, Plant, and Equipment	39K	-	-	-	-
Cash Acquisitions	-	-	-	-	-
Other Investing Activities, Total	-	6.53M	383K	-	-
Cash from Investing	-315K	6.21M	-87K	-876K	-356K
Short Term Debt Issued, Total	7.5M	2M	-	-	-
Long-Term Debt Issued, Total	9.5M	1M	-	-	-
Total Debt Issued	17M	3M	-	-	-
Short Term Debt Repaid, Total	-7.92M	-	-	-	-
Long-Term Debt Repaid, Total	-	-	-2.5M	-5.6M	-4.4M
Total Debt Repaid	-7.92M	-	-2.5M	-5.6M	-4.4M
Issuance of Common Stock	335K	108K	-	-	-
Repurchase of Common Stock	-	-108K	-32K	-46K	-18K
Issuance of Preferred Stock	-	-	-	-	-
Other Financing Activities, Total	-435K	-	-2.5M	-161K	-13K
Cash from Financing	8.98M	3M	-5.03M	-5.81M	-4.43M
Net Change in Cash	-58K	1.51M	-1.33M	-2.04M	1.04M
Supplemental Items
Cash Interest Paid	424K	971K	1.09M	625K	168K
Cash Income Tax Paid (Refund)	369K	251K	270K	274K	101K
Levered Free Cash Flow	-1.62M	-1.04M	4.22M	1.41M	5.09M
Unlevered Free Cash Flow	-1.17M	-472K	4.81M	1.82M	5.14M
Change In Net Working Capital	219K	1.55M	-1.29M	3.41M	-1.65M
Net Debt Issued / Repaid	9.08M	3M	-2.5M	-5.6M	-4.4M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-17.44	-8.82	12.12	36.32	12.3
Return on Total Capital	-36.65	-33.34	-80.06	173.9	22
Return On Equity %	-136.72	94.46	-7.02	-123.81	248.03
Return on Common Equity	41.25	11.12	-1.78	-22.45	248.03
Margin Analysis
Gross Profit Margin %	43.44	57.26	59.44	63.77	62.31
SG&A Margin	57.45	63.13	48.73	45.05	48.3
EBITDA Margin %	-16.13	-4.02	9.54	17.92	13.45
EBITA Margin %	-18.57	-8.07	9.13	17.28	12.35
EBIT Margin %	-28.41	-12.06	6.99	17.28	12.35
Income From Continuing Operations Margin %	-35.69	-18.42	2.77	14.8	64.51
Net Income Margin %	-36.17	-68.97	1.99	14.28	63.46
Net Avail. For Common Margin %	-35.69	-18.42	2.77	13.81	64.51
Normalized Net Income Margin	-19.92	-11.89	1.77	9.26	7.22
Levered Free Cash Flow Margin	-3.92	-3.27	10.5	3	13.14
Unlevered Free Cash Flow Margin	-2.82	-1.48	11.97	3.88	13.26
Asset Turnover
Asset Turnover	0.98	1.17	2.77	3.36	1.59
Fixed Assets Turnover	3.74	14.09	14.43	16.68	13.8
Receivables Turnover (Average Receivables)	5.82	6.56	8.03	6.89	5.46
Inventory Turnover (Average Inventory)	12.18	13.28	13.31	13.95	12.56
Short Term Liquidity
Current Ratio	0.78	0.85	0.59	1.11	1.94
Quick Ratio	0.59	0.69	0.49	0.94	1.6
Operating Cash Flow to Current Liabilities	-0.56	-0.54	0.22	0.44	1.14
Days Sales Outstanding (Average Receivables)	62.67	55.62	45.45	53.12	66.88
Days Outstanding Inventory (Average Inventory)	29.97	27.48	27.43	26.24	29.07
Average Days Payable Outstanding	56.92	31.58	29.02	34.51	33.25
Cash Conversion Cycle (Average Days)	35.72	51.52	43.86	44.86	62.7
Long Term Solvency
Total Debt/Equity	333.07	-97.31	-73.94	-264.14	5.29
Total Debt / Total Capital	76.91	-3.62K	-283.77	160.92	5.02
LT Debt/Equity	305.88	-78.69	-37.76	-53.36	3.36
Long-Term Debt / Total Capital	70.63	-2.92K	-144.9	32.51	3.19
Total Liabilities / Total Assets	89.28	203.49	216.24	114.99	33.91
EBIT / Interest Expense	-12.76	-3.81	2.79	12.3	28.48
EBITDA / Interest Expense	-5.94	-0.38	4.6	13.82	34.58
(EBITDA - Capex) / Interest Expense	-6.32	-0.7	4.13	12.49	32.46
Total Debt / EBITDA	-2.51	-42.34	2.41	0.64	0.2
Net Debt / EBITDA	-1.95	-29.64	1.66	0.48	-0.23
Total Debt / (EBITDA - Capex)	-2.36	-22.92	2.69	0.71	0.22
Net Debt / (EBITDA - Capex)	-1.83	-16.04	1.85	0.53	-0.24
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	27.52	-3.86	26.31	17.21	-17.47
Gross Profit, 1 Yr. Growth %	67.32	-3.04	31.12	19.43	-19.37
EBITDA, 1 Yr. Growth %	-63.94	228.21	-399.77	68.53	-38.05
EBITA, 1 Yr. Growth %	-60.68	-0.08	-242.88	68.08	-41
EBIT, 1 Yr. Growth %	-51.05	-33.38	-173.2	104.59	-41
Earnings From Cont. Operations, 1 Yr. Growth %	-43.72	-16.65	-118.96	206.8	259.69
Net Income, 1 Yr. Growth %	-43.51	46.94	-103.65	242.99	266.68
Normalized Net Income, 1 Yr. Growth %	-45.28	-15.65	-118.75	203.76	-35.63
Diluted EPS Before Extra, 1 Yr. Growth %	-50.83	-18.68	-118.06	-21.15	-36.17
Accounts Receivable, 1 Yr. Growth %	-23.29	7.71	-0.97	68.26	-33.88
Inventory, 1 Yr. Growth %	-12.96	48.36	0.24	-1.3	-8.01
Net Property, Plant and Equip., 1 Yr. Growth %	-11.52	82.32	-9.08	12.06	-11.23
Total Assets, 1 Yr. Growth %	-15.88	-58.42	-18.51	12.78	128.76
Tangible Book Value, 1 Yr. Growth %	18.97	43.51	-3.54	-96.01	-1.11K
Common Equity, 1 Yr. Growth %	45.85	48.69	-2.22	-96.01	-1.11K
Cash From Operations, 1 Yr. Growth %	-37.63	-11.78	-149.26	22.62	25.51
Capital Expenditures, 1 Yr. Growth %	-77.52	-9.04	45.96	86.38	-59.36
Levered Free Cash Flow, 1 Yr. Growth %	-68.12	-158.49	-12.9K	-218.46	261.35
Unlevered Free Cash Flow, 1 Yr. Growth %	-75.37	-120.44	796.07	-402.85	182.18
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	30.61	-0.87	10.2	21.4	-1.65
Gross Profit, 2 Yr. CAGR %	46.76	30.38	12.75	28.12	-1.87
EBITDA, 2 Yr. CAGR %	-41.43	-73.68	213.66	156.3	2.18
EBITA, 2 Yr. CAGR %	-37.99	-63.71	19.49	77.62	-0.42
EBIT, 2 Yr. CAGR %	-29.99	-59.98	-30.17	45.31	9.87
Earnings From Cont. Operations, 2 Yr. CAGR %	-25.62	-52.69	-60.25	8.83	232.19
Net Income, 2 Yr. CAGR %	-25.25	-8.89	-76.83	-44.75	254.64
Normalized Net Income, 2 Yr. CAGR %	-26.23	-49.82	-60.23	7.1	39.84
Diluted EPS Before Extra, 2 Yr. CAGR %	-29.73	-56.34	-61.67	-45.57	31.56
Accounts Receivable, 2 Yr. CAGR %	-22.82	-20.83	3.27	30.3	5.47
Inventory, 2 Yr. CAGR %	-1.07	-22.77	21.95	-0.53	-4.72
Net Property, Plant and Equip., 2 Yr. CAGR %	-1.53	-50.12	28.75	0.94	-0.26
Total Assets, 2 Yr. CAGR %	-13.65	-40.86	-41.79	-3.79	60.62
Tangible Book Value, 2 Yr. CAGR %	42.18	14.38	17.66	-81.38	-36.55
Common Equity, 2 Yr. CAGR %	207.74	47.26	20.58	-81.25	-36.55
Cash From Operations, 2 Yr. CAGR %	-32.18	-25.82	-34.08	-22.28	24.05
Capital Expenditures, 2 Yr. CAGR %	64.39	-54.78	15.23	64.94	-12.97
Levered Free Cash Flow, 2 Yr. CAGR %	-40.37	-54.71	53.98	553.34	106.89
Unlevered Free Cash Flow, 2 Yr. CAGR %	-47.79	-68.43	44.34	84.12	192.33
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	23.57	9.54	7.47	12.32	6.75
Gross Profit, 3 Yr. CAGR %	15.33	29.82	30.62	16.75	9.79
EBITDA, 3 Yr. CAGR %	-2.25	-59.61	-40.78	178.32	59.65
EBITA, 3 Yr. CAGR %	1.47	-49.5	-42.7	46.63	23.01
EBIT, 3 Yr. CAGR %	3.46	-45.67	-51.06	12.05	7.6
Earnings From Cont. Operations, 3 Yr. CAGR %	6.51	-39.63	-65.12	-0.43	62.11
Net Income, 3 Yr. CAGR %	7.03	-6.36	-68.82	-23.45	3.82
Normalized Net Income, 3 Yr. CAGR %	7.27	-36.96	-63.86	-1.09	-9.61
Diluted EPS Before Extra, 3 Yr. CAGR %	-6.26	-42.37	-67.47	-37.78	-13.36
Accounts Receivable, 3 Yr. CAGR %	-13.4	-21.34	-14.7	22.29	3.93
Inventory, 3 Yr. CAGR %	-	-12.47	-15.75	13.65	-3.09
Net Property, Plant and Equip., 3 Yr. CAGR %	131.48	-35.16	-39.07	22.93	-3.29
Total Assets, 3 Yr. CAGR %	-7.43	-32.32	-34.19	-27.26	28.42
Tangible Book Value, 3 Yr. CAGR %	166.11	30.51	8.07	-63.22	-29.54
Common Equity, 3 Yr. CAGR %	8.8	141.48	28.47	-62.61	-29.22
Cash From Operations, 3 Yr. CAGR %	0.18	-25.97	-35.28	-18.93	-8.82
Capital Expenditures, 3 Yr. CAGR %	-7.62	34.96	-33.18	35.26	3.4
Levered Free Cash Flow, 3 Yr. CAGR %	-41.73	-38.84	-5.96	-7.53	436.29
Unlevered Free Cash Flow, 3 Yr. CAGR %	-47.32	-52.04	0.53	-7.62	112.28
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	25.85	14.9	12.93	14.14	3.63
Gross Profit, 5 Yr. CAGR %	22.73	16.38	15.36	29.14	17.61
EBITDA, 5 Yr. CAGR %	-8.62	-33.31	-11.66	-15.42	-22.37
EBITA, 5 Yr. CAGR %	-7.23	-24.01	-12.95	-16.49	-24.51
EBIT, 5 Yr. CAGR %	-4.71	-22.11	-23.31	-19.47	-27.56
Earnings From Cont. Operations, 5 Yr. CAGR %	11.89	-14.37	-38.07	-23.58	-0.95
Net Income, 5 Yr. CAGR %	12.39	12.44	-41.97	-24.18	-1.46
Normalized Net Income, 5 Yr. CAGR %	-5.06	-17.61	-36.1	-22.08	-28.57
Diluted EPS Before Extra, 5 Yr. CAGR %	-40.1	-29.77	-43.48	-43.67	-34.13
Accounts Receivable, 5 Yr. CAGR %	22.76	7.92	-12.08	-3.74	-6.79
Inventory, 5 Yr. CAGR %	-	-	-	-7.88	-11.5
Net Property, Plant and Equip., 5 Yr. CAGR %	62.05	34.87	25.96	-22.6	-25.79
Total Assets, 5 Yr. CAGR %	-1.66	-21.5	-23.11	-22.09	-5.83
Tangible Book Value, 5 Yr. CAGR %	14.28	56.71	82.04	-40.1	-14.47
Common Equity, 5 Yr. CAGR %	45.38	9.61	13.36	-13.12	-5.12
Cash From Operations, 5 Yr. CAGR %	2.77	-12.81	-15.26	-24.51	-16.04
Capital Expenditures, 5 Yr. CAGR %	-	61.84	0.92	46.23	-25.73
Levered Free Cash Flow, 5 Yr. CAGR %	-19.93	-39.36	-12.4	-20.92	0.04
Unlevered Free Cash Flow, 5 Yr. CAGR %	-20.09	-48.12	-9.62	-15.71	1.64